NO985977D0 - Spiro-piperidinderivater og deres anvendelse som terapeutiske midler - Google Patents

Spiro-piperidinderivater og deres anvendelse som terapeutiske midler

Info

Publication number: NO985977D0
Authority: NO; Norway
Prior art keywords: spiro; therapeutic agents; piperidine derivatives; piperidine; derivatives
Prior art date: 1996-06-21

Application number

NO985977A

Other languages

English (en)

Other versions

NO985977L (no

Inventor

Raymond Baker

Neil Roy Curtis

Jason Matthew Elliott

Timothy Harrison

Gregory John Hollingworth

Philip Stephen Jackson

Janusz Jozef Kulagowski

Eileen Mary Seward

Christopher John Swain

Brian John Williams

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-21

Filing date

1998-12-18

Publication date

1998-12-18

1996-06-21 Priority claimed from GBGB9613108.1A external-priority patent/GB9613108D0/en

1996-12-02 Priority claimed from GB9625051A external-priority patent/GB9625051D0/en

1996-12-20 Priority claimed from GBGB9626593.9A external-priority patent/GB9626593D0/en

1997-01-24 Priority claimed from GB9701459A external-priority patent/GB9701459D0/en

1997-05-23 Priority claimed from GBGB9710748.6A external-priority patent/GB9710748D0/en

1997-05-23 Priority claimed from GBGB9710747.8A external-priority patent/GB9710747D0/en

1997-05-23 Priority claimed from GBGB9710743.7A external-priority patent/GB9710743D0/en

1998-12-18 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

1998-12-18 Publication of NO985977D0 publication Critical patent/NO985977D0/no

1999-02-22 Publication of NO985977L publication Critical patent/NO985977L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO985977A 1996-06-21 1998-12-18 Spiro-piperidinderivater og deres anvendelse som terapeutiske midler NO985977L (no)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
GBGB9613108.1A GB9613108D0 (en)	1996-06-21	1996-06-21	Therapeutic agents
GB9625051A GB9625051D0 (en)	1996-12-02	1996-12-02	Therapeutic agents
GBGB9626593.9A GB9626593D0 (en)	1996-12-20	1996-12-20	Therapeutic agents
GB9701459A GB9701459D0 (en)	1997-01-24	1997-01-24	Therapeutic agents
GBGB9710748.6A GB9710748D0 (en)	1997-05-23	1997-05-23	Therapeutic agents
GBGB9710747.8A GB9710747D0 (en)	1997-05-23	1997-05-23	Therapeutic agents
GBGB9710743.7A GB9710743D0 (en)	1997-05-23	1997-05-23	Therapeutic agents
PCT/GB1997/001630 WO1997049710A1 (en)	1996-06-21	1997-06-17	Spiro-piperidine derivatives and their use as therapeutic agents

Publications (2)

Publication Number	Publication Date
NO985977D0 true NO985977D0 (no)	1998-12-18
NO985977L NO985977L (no)	1999-02-22

Family

ID=27562932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO985977A NO985977L (no)	1996-06-21	1998-12-18	Spiro-piperidinderivater og deres anvendelse som terapeutiske midler

Country Status (19)

Country	Link
US (1)	US6071927A (no)
EP (1)	EP0906315A1 (no)
JP (1)	JP2000510153A (no)
KR (1)	KR20000022060A (no)
AU (1)	AU722541B2 (no)
BG (1)	BG102998A (no)
BR (1)	BR9709915A (no)
CA (1)	CA2257964A1 (no)
CZ (1)	CZ424798A3 (no)
EA (1)	EA001574B1 (no)
EE (1)	EE9800459A (no)
IL (1)	IL126900A0 (no)
NO (1)	NO985977L (no)
NZ (1)	NZ332777A (no)
PL (1)	PL330235A1 (no)
SK (1)	SK175398A3 (no)
TR (1)	TR199802667T2 (no)
WO (1)	WO1997049710A1 (no)
YU (1)	YU59098A (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU715558B2 (en) *	1995-11-23	2000-02-03	Merck Sharp & Dohme Limited	Spiro-piperidine derivatives and their use as tachykinin antagonists
EP0912174B1 (en) *	1996-07-17	2004-04-28	MERCK & CO., INC.	Alteration of circadian rhythmicity with non-peptidal neurikinin-1 receptor antagonists
US5929094A (en) *	1996-10-25	1999-07-27	Merck & Co., Inc.	Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
GB9625843D0 (en) *	1996-12-12	1997-01-29	Merck & Co Inc	Phenyl spiroethercycloalkyl tachykinn receptor antagonists
AU731672B2 (en) *	1996-12-02	2001-04-05	Merck Sharp & Dohme Limited	Use of NK-1 receptor antagonists for treating bipolar disorders
US5977104A (en) *	1996-12-02	1999-11-02	Merck Sharp & Dohme Ltd.	Use of NK-1 receptor antagonists for treating bipolar disorders
WO1998047513A1 (en) *	1997-04-24	1998-10-29	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating eating disorders
GB9716463D0 (en) *	1997-08-04	1997-10-08	Merck Sharp & Dohme	Therapeutic agents
CA2298779A1 (en) *	1997-08-04	1999-02-18	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
CA2298777A1 (en) *	1997-08-04	1999-02-18	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating mania
GB9812617D0 (en) *	1998-06-11	1998-08-12	Merck Sharp & Dohme	Therapeutic use
GB9812662D0 (en) *	1998-06-11	1998-08-12	Merck Sharp & Dohme	Therapeutic use
GB9816897D0 (en) *	1998-08-04	1998-09-30	Merck Sharp & Dohme	Therapeutic use
GB9902881D0 (en) *	1999-02-09	1999-03-31	Merck Sharp & Dohme	Therapeutic agents
GB0004699D0 (en)	2000-02-28	2000-04-19	Merck Sharp & Dohme	Chemical synthesis
US20050042194A1 (en)	2000-05-11	2005-02-24	A.P. Pharma, Inc.	Semi-solid delivery vehicle and pharmaceutical compositions
GB0017256D0 (en)	2000-07-13	2000-08-30	Merck Sharp & Dohme	Therapeutic agents
DE10040051A1 (de) *	2000-08-11	2002-02-21	Basf Ag	Derivate des 4-(Trifluormethyl)-phenols sowie Derivate des 4-(Trifluormethylphenyl)-2-(tetrahydropyranyl)ethers und Verfahren zu ihre Herstellung
US20020103110A1 (en) *	2001-01-26	2002-08-01	Spitzer A. Robert	System and method for rectal administration of medication for treatment of migraines
GB0108973D0 (en) *	2001-04-10	2001-05-30	Merck Sharp & Dohme	Therapeutic agents
GB0121874D0 (en) *	2001-09-10	2001-10-31	Merck Sharp & Dohme	Therapeutic agents
US6673792B1 (en) *	2002-07-11	2004-01-06	Upchuck, Llc	Broad-spectrum anti-emetic compositions and associated methods
US7442698B2 (en)	2003-07-24	2008-10-28	Amgen Inc.	Substituted heterocyclic compounds and methods of use
MX2007000428A (es)	2004-07-15	2008-03-05	Amr Technology Inc	Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina.
UA95454C2 (uk)	2005-07-15	2011-08-10	Амр Текнолоджи, Інк.	Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
EP1940842B1 (en)	2005-09-29	2012-05-30	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
EP2083831B1 (en)	2006-09-22	2013-12-25	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
JP2010516731A (ja)	2007-01-24	2010-05-20	グラクソグループリミテッド	２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
AU2008233662B2 (en)	2007-04-02	2012-08-23	Msd K.K.	Indoledione derivative
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
KR20120023072A (ko)	2009-05-12	2012-03-12	브리스톨-마이어스 스큅 컴퍼니	（Ｓ）-7-（〔1,2,4〕트리아졸〔1,5-ａ〕피리딘-6-일）-4-（3,4-디클로로페닐）-1,2,3,4-테트라하이드로이소퀴놀린의 결정형 및 이의 용도
MX2011011901A (es)	2009-05-12	2012-01-20	Albany Molecular Res Inc	Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
MX2011011907A (es)	2009-05-12	2012-01-20	Albany Molecular Res Inc	7-([1,2,4,]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2, 3,4-tetrahidroisoquinolina y uso de la misma.
WO2014142761A1 (en)	2013-03-15	2014-09-18	Nanyang Technological University	3-piperidone compounds and their use as neurokinin-1 (nk1) receptor antagonists
WO2022015628A2 (en) *	2020-07-15	2022-01-20	St. Jude Children's Research Hospital, Inc.	Obese ferret model and methods of establishing and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2154569A1 (en) *	1993-01-28	1994-08-04	Jeffrey J. Hale	Spiro-substituted azacycles as tachykinin receptor antagonists
EP0687268B1 (en) *	1993-03-04	1998-05-27	Pfizer Inc.	Spiroazacyclic derivatives as substance p antagonists
JPH08511522A (ja) *	1993-06-07	1996-12-03	メルクエンドカンパニーインコーポレーテッド	ニューロキニンアンタゴニストとしてのスピロ置換アザ環
GB9417956D0 (en) *	1994-09-02	1994-10-26	Merck Sharp & Dohme	Therapeutic agents
GB9426103D0 (en) *	1994-12-23	1995-02-22	Merck Sharp & Dohme	Therapeutic agents
AU715558B2 (en) *	1995-11-23	2000-02-03	Merck Sharp & Dohme Limited	Spiro-piperidine derivatives and their use as tachykinin antagonists

1997
- 1997-06-17 CZ CZ984247A patent/CZ424798A3/cs unknown
- 1997-06-17 PL PL97330235A patent/PL330235A1/xx unknown
- 1997-06-17 TR TR1998/02667T patent/TR199802667T2/xx unknown
- 1997-06-17 US US09/202,493 patent/US6071927A/en not_active Expired - Fee Related
- 1997-06-17 EA EA199900045A patent/EA001574B1/ru not_active IP Right Cessation
- 1997-06-17 SK SK1753-98A patent/SK175398A3/sk unknown
- 1997-06-17 AU AU31020/97A patent/AU722541B2/en not_active Ceased
- 1997-06-17 JP JP10502496A patent/JP2000510153A/ja not_active Withdrawn
- 1997-06-17 BR BR9709915A patent/BR9709915A/pt unknown
- 1997-06-17 EP EP97926140A patent/EP0906315A1/en not_active Withdrawn
- 1997-06-17 IL IL12690097A patent/IL126900A0/xx unknown
- 1997-06-17 KR KR1019980710463A patent/KR20000022060A/ko not_active Application Discontinuation
- 1997-06-17 YU YU59098A patent/YU59098A/sh unknown
- 1997-06-17 WO PCT/GB1997/001630 patent/WO1997049710A1/en not_active Application Discontinuation
- 1997-06-17 EE EE9800459A patent/EE9800459A/xx unknown
- 1997-06-17 NZ NZ332777A patent/NZ332777A/en unknown
- 1997-06-17 CA CA002257964A patent/CA2257964A1/en not_active Abandoned
1998
- 1998-12-08 BG BG102998A patent/BG102998A/xx unknown
- 1998-12-18 NO NO985977A patent/NO985977L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU722541B2 (en)	2000-08-03
EA199900045A1 (ru)	1999-06-24
BR9709915A (pt)	1999-08-10
BG102998A (en)	1999-09-30
NO985977L (no)	1999-02-22
TR199802667T2 (xx)	1999-03-22
PL330235A1 (en)	1999-05-10
SK175398A3 (en)	2000-04-10
EA001574B1 (ru)	2001-06-25
CA2257964A1 (en)	1997-12-31
JP2000510153A (ja)	2000-08-08
CZ424798A3 (cs)	1999-05-12
WO1997049710A1 (en)	1997-12-31
IL126900A0 (en)	1999-09-22
NZ332777A (en)	2000-06-23
EE9800459A (et)	1999-06-15
YU59098A (sh)	2002-06-19
KR20000022060A (ko)	2000-04-25
US6071927A (en)	2000-06-06
EP0906315A1 (en)	1999-04-07
AU3102097A (en)	1998-01-14

Publication	Publication Date	Title
NO985977D0 (no)	1998-12-18	Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
DK0906292T3 (da)	2003-10-27	Triazolylmercaptider og deres anvendelse som mikrobicider
DK0869126T3 (da)	2002-11-18	Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO990965D0 (no)	1999-02-26	Terapeutiske fremgangsmÕter og blandinger som inneholder isoflavoner
GB9515775D0 (en)	1995-10-04	Piperidine derivatives and their use as therapeutic agents
NO971811D0 (no)	1997-04-18	Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO983187L (no)	1998-09-09	Substituerte aza- og diazacykloheptan og -cyklooktan-forbindelse og deres anvendelse
NO984761D0 (no)	1998-10-12	Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO943682D0 (no)	1994-10-03	Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO944187D0 (no)	1994-11-03	Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse
NO20003067L (no)	2000-08-15	Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO994510L (no)	1999-09-17	Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
DK0764157T3 (da)	2002-04-22	Benzopyraner og deres anvendelse som terapeutiske midler
NO995513L (no)	2000-01-12	N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO975020D0 (no)	1997-10-31	Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
NO992676D0 (no)	1999-06-02	1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO962477D0 (no)	1996-06-12	Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO940130D0 (no)	1994-01-14	Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO954763D0 (no)	1995-11-24	Piperidinderivater, deres fremstilling og anvendelse
DK0835254T3 (da)	2000-03-27	Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO972256D0 (no)	1997-05-16	O-Benzyloksimeterderivater og deres anvendelse som pesticider
NO991581D0 (no)	1999-03-30	N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
NO20030547L (no)	2003-02-04	Azabicykliske derivater og deres terapeutiske anvendelse
NO955242D0 (no)	1995-12-22	Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO984921D0 (no)	1998-10-22	Tienopyridinderivater og deres anvendelse

Legal Events

Date	Code	Title	Description
2003-02-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application